ダウンロード数: 251

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
49_5.pdf335.09 kBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.authorYamanaka, Kazukien
dc.contributor.authorYamada, Yujien
dc.contributor.authorKobayashi, Yasuhiroen
dc.contributor.authorUeno, Koichien
dc.contributor.authorTakechi, Yoshizumien
dc.contributor.authorHasegawa, Emien
dc.contributor.authorChikahira, Yoshimien
dc.contributor.alternative山中, 和樹ja
dc.contributor.alternative山田, 裕二ja
dc.contributor.alternative小林, 康浩ja
dc.contributor.alternative上野, 康一ja
dc.contributor.alternative武市, 佳純ja
dc.contributor.alternative長谷川, 絵美ja
dc.contributor.alternative近平, 佳美ja
dc.date.accessioned2010-05-27T07:19:04Z-
dc.date.available2010-05-27T07:19:04Z-
dc.date.issued2003-01-
dc.identifier.issn0018-1994-
dc.identifier.urihttp://hdl.handle.net/2433/114903-
dc.description.abstract対象は1999年7月から28ヵ月間に超音波ガイド下経直腸的前立腺生検を施行したPSA2.0~10.0ng/mlの151例で, PSA, PSA-ACT, PSAD, PSATZD, PSA-ACTD, PSA-ACTTZDを測定し, ROC解析を用いてこれらのパラメーターを検討した.系統的6ヶ所生検にて151例中36例から前立腺癌が検出された.ROC解析ではPSA-ACTTZDのAUCが最大となり, PSA-ACTTZDは有意差をもってPSA単独より有用な指標と考えられた.PSA-ACTTZDのカットオフ値を0.20ng/ml2を設定することにより, 感度90%, 特異度55%で不必要な生検を回避できる可能性が示唆されたja
dc.description.abstractWe examined the usefulness of prostate specific antigen alph-1-antichymotrypsin complex (PSA-ACT) and its indices for the detection of prostate cancer in patients with a prostate specific antigen (PSA) level between 2.1 and 10.0 ng/ml. Between July 1999 and October 2001, 151 patients with a PSA level between 2.1 and 10.0 ng/ml underwent a systematic biopsy under transrectal ultrasound (TRUS) guidance. The clinical values of total PSA, PSA-ACT, PSA density (PSAD), PSA-ACT density (PSA-ACTD), PSA transition zone density (PSATZD) and PSA-ACT transition zone density (PSA-ACTTZD) for the detection of prostate cancer were compared by using receiver operating characteristic (ROC) curve analysis. Of the 151 patients, 36 (23.8%) were histologically confirmed as having prostate cancer. The differences between patients with prostate cancer and benign prostatic disease were significant with respect to the PSA and PSA-ACT related parameters examined in this study. According to ROC curve analysis, the area under the curve (AUC) of PSA-ACTTZD was the greatest of all the parameters. The differences was significant between the AUC of PSA-ACTTZD and total PSA (p < 0.05). The cutoff value of PSA-ACTTZD with 0.20 ng/ml2 showed the highest sum of sensivitity (90%) and specificity (55%). Also, in 86 patients with a PSA level between 2.1 and 6.0 ng/ml, the AUC of PSA-ACTTZD was the greatest of all the parameters. Measuring the level of PSA-ACT and its indices may provide a better differentiation of prostate cancer and benign prostatic disease than total PSA alone in patients with intermediate PSA levels. PSA-ACTTZD is the most useful indicator among PSA-ACT and its volume indices.en
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisher泌尿器科紀要刊行会ja
dc.subjectProstate canceren
dc.subjectProstate specific antigen alpha-l-antichymotrypsinen
dc.subjectTranstion zoneen
dc.subject.ndc494.9-
dc.titleThe significance of prostate-specific antigen alpha-1-antichymotrypsin complex and its indices for the detection of prostate canceren
dc.title.alternative前立腺癌診断におけるPSA-ACTおよびPSA-ACT volume indexの有用性についての検討ja
dc.typedepartmental bulletin paper-
dc.type.niitypeDepartmental Bulletin Paper-
dc.identifier.ncidAN00208315-
dc.identifier.jtitle泌尿器科紀要ja
dc.identifier.volume49-
dc.identifier.issue1-
dc.identifier.spage5-
dc.identifier.epage10-
dc.textversionpublisher-
dc.sortkey02-
dc.addressDepartment of Urology, Hyogo Prefectural Awaji Hospitalen
dc.addressDepartment of Laboratory Medicine, Hyogo Prefectural Awaji Hospital.en
dc.address.alternative兵庫県立淡路病院 泌尿器科ja
dc.address.alternative兵庫県立淡路病院検査部ja
dc.identifier.pmid12629773-
dcterms.accessRightsopen access-
dc.identifier.pissn0018-1994-
dc.identifier.jtitle-alternativeActa urologica Japonicala
dc.identifier.jtitle-alternativeHinyokika Kiyoen
出現コレクション:Vol.49 No.1

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。